Dewailly D - Search Results

1

Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.

Bertherat J, Chanson P, Dewailly D, Enjalbert A, Jaquet P, Kordon C, Peillon F, Timsit J, Epelbaum J. Bertherat J, et al. Among authors: dewailly d. Horm Res. 1992;38(1-2):94-9. doi: 10.1159/000182500. Horm Res. 1992. PMID: 1306525 Review.

2

Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.

Brue T, Pellegrini I, Gunz G, Morange I, Dewailly D, Brownell J, Enjalbert A, Jaquet P. Brue T, et al. Among authors: dewailly d. J Clin Endocrinol Metab. 1992 Mar;74(3):577-84. doi: 10.1210/jcem.74.3.1346788. J Clin Endocrinol Metab. 1992. PMID: 1346788

3

A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.

Brue T, Lancranjan I, Louvet JP, Dewailly D, Roger P, Jaquet P. Brue T, et al. Among authors: dewailly d. Fertil Steril. 1992 Jan;57(1):74-80. Fertil Steril. 1992. PMID: 1730334 Free article. Clinical Trial.

4

Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma.

Wémeau JL, Dewailly D, Leroy R, D'Herbomez M, Mazzuca M, Decoulx M, Jaquet P. Wémeau JL, et al. Among authors: dewailly d, d herbomez m. J Clin Endocrinol Metab. 1988 Mar;66(3):636-9. doi: 10.1210/jcem-66-3-636. J Clin Endocrinol Metab. 1988. PMID: 2895119

5

Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.

Bertherat J, Chanson P, Dewailly D, Dupuy M, Jaquet P, Peillon F, Epelbaum J. Bertherat J, et al. Among authors: dewailly d. J Clin Endocrinol Metab. 1993 Dec;77(6):1577-83. doi: 10.1210/jcem.77.6.7903312. J Clin Endocrinol Metab. 1993. PMID: 7903312

6

Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.

Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, Dewailly D, Jaquet P, Kordon C, Enjalbert A. Caccavelli L, et al. Among authors: dewailly d. Neuroendocrinology. 1994 Sep;60(3):314-22. doi: 10.1159/000126764. Neuroendocrinology. 1994. PMID: 7969790

7

Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide.

Morange I, De Boisvilliers F, Chanson P, Lucas B, DeWailly D, Catus F, Thomas F, Jaquet P. Morange I, et al. Among authors: dewailly d. J Clin Endocrinol Metab. 1994 Jul;79(1):145-51. doi: 10.1210/jcem.79.1.8027218. J Clin Endocrinol Metab. 1994. PMID: 8027218

8

Insulin resistance and polycystic ovarian syndrome.

Dewailly D, Cortet-Rudelli C. Dewailly D, et al. Horm Res. 1992;38(1-2):41-5. doi: 10.1159/000182482. Horm Res. 1992. PMID: 1306514 Review.

9

[Short-term effect of delayed-action injectable bromocriptine in macroprolactinoma. French multicenter study].

Brue T, James-Deidier A, Louvet JP, Dewailly D, Roger P, Schlienger JL, Schaison G, Hartemann P, Jaquet P. Brue T, et al. Among authors: dewailly d. Ann Endocrinol (Paris). 1991;52(4):273-82. Ann Endocrinol (Paris). 1991. PMID: 1818531 Clinical Trial. French.

10

Adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in alcohol dependence disorder. Preliminary report.

Bailly D, Dewailly D, Beuscart R, Couplet G, Dumont P, Racadot A, Fossati P, Parquet PJ. Bailly D, et al. Among authors: dewailly d. Horm Res. 1989;31(1-2):72-5. doi: 10.1159/000181090. Horm Res. 1989. PMID: 2542148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters